Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      The Galien Foundation Honors Excellence in Scientific Innovation at 2021 Prix Galien Awards Gala

      Winners receive the ultimate recognition for innovation that improves the human condition


      News provided by

      The Galien Foundation

      Oct 29, 2021, 09:00 ET

      Share this article

      Share this article


      NEW YORK, Oct. 29, 2021 /PRNewswire/ -- The Prix Galien USA Committee last night honored excellence in the pharmaceutical, biotechnology, medical device and digital health industry for research, development and innovation at its 15th annual Prix Galien Awards Gala at the American Museum of Natural History in New York City. The ceremony commemorated the last 50 years of innovations that have improved the human condition and honored winners for "Best Biotechnology Product," "Best Pharmaceutical Agent," "Best Medical Technology," and "Best Digital Health Solution." Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize for the life science industry.

      Continue Reading
      Left to right: Alcon, Huma, Novartis Pharmaceuticals Corporation, Global Blood Therapeutics, Inc. (GBT)
      Left to right: Alcon, Huma, Novartis Pharmaceuticals Corporation, Global Blood Therapeutics, Inc. (GBT)
      (PRNewsfoto/The Galien Foundation)
      (PRNewsfoto/The Galien Foundation)

      The 2021 Prix Galien USA Award Winners

      Best Biotechnology Product

      Global Blood Therapeutics, Inc. (GBT)

      Oxbryta® (voxelotor) tablets

      Best Pharmaceutical Agent

      Novartis Pharmaceuticals Corporation

      Entresto® (sacubitril/valsartan)

      Best Medical Technology

      Alcon

      AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL)

      Best Digital Health Solution

      Huma

      Huma Therapeutic's Remote Patient Monitoring Platform

      "This year, it is particularly special to honor these extraordinary companies for their dedication to research, development and innovation throughout one of the most trying and uncertain times this industry has ever seen," said Bruno Cohen, Chairman of The Galien Foundation. "Their commitment to furthering their work is admirable and we are thrilled to recognize that through the Prix Galien Awards."

      Today, join us at 12pm ET for an exchange, moderated by Alexandra Von Plato, CEO of Publicis Health, with leaders from each of the 4 winning companies. Additionally, hear an update on Prix Galien Africa from Pr. Awa Mari Coll-Seck, Minister of State of Senegal, CN-EITI Chair, and President of the Scientific Committee of the 4th Galien Forum Africa and Prize, which will take place on December 11, 2021 in Dakar, Senegal.

      Additionally, the Roy Vagelos Pro Bono Humanum Award for Global Health Equity was presented to the six world-leading biopharmaceutical companies responsible for development of COVID-19 vaccines and therapeutics. Awards were presented to senior leaders from COVID-19 vaccine makers Pfizer/BioNTech SE, Moderna Inc., AstraZeneca PLC, and Johnson & Johnson, as well as top executives representing Regeneron Pharmaceuticals, which received Emergency Use Authorization (EUA) for the investigational COVID-19 antibody cocktail REGEN-COV™ (casirivimab and imdevimab), and Eli Lilly & Company, which received EUA for bamlanivimab.

      "On behalf of the Prix Galien USA Awards Committee, we want to thank all nominees and winners for their dedication to advancing human life," said Dr. Sue Desmond-Hellmann, Chair of the Prix Galien USA and Prix Galien International Award Committees and former CEO of the Bill & Melinda Gates Foundation. "Their tireless dedication to research, development and innovation has been critical in improving health and wellness of countless individuals around the world."

      Prix Galien Awards Committee 2021

      Sue DESMOND-HELLMANN, M.D., M.P.H.
      Former Chief Executive Officer, Bill & Melinda Gates Foundation
      Committee Chair

      Richard AXEL, M.D.
      Nobel Laureate, Co-director, The Kavli Institute for Brain Science; Professor, Columbia University Medical Center

      Linda BUCK, Ph.D.
      Nobel Laureate, Fred Hutchinson Cancer Research Center member; Professor of Physiology and Biophysics, University of Washington

      Laurie GLIMCHER, M.D.
      President and CEO, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School

      Mary-Claire KING, Ph.D.
      American Cancer Society Professor of Genome Sciences and Medical Genetics, University of Washington

      Robert S. LANGER, M.D.
      David H. Koch Institute Professor, Massachusetts Institute of Technology

      Cato T. LAURENCIN, M.D., Ph.D.
      University Professor, University of Connecticut

      Steven J. LESTER, M.D.
      Chief Medical Officer, Mayo Clinic-ASU MedTech Accelerator

      Michael ROSENBLATT, M.D.
      Chief Medical Officer, Flagship Pioneering

      Bengt SAMUELSSON, M.D., Ph.D.
      Nobel Laureate; Professor Karolinska Institutet; Former President, Karolinska institute; Former Chairman, Nobel Foundation

      Marc TESSIER-LAVIGNE, Ph.D.
      President, Stanford University

      Tachi YAMADA, M.D.
      Venture Partner, Frazier Healthcare Partners, In Memoriam

      Elie WIESEL
      Nobel Peace Prize Laureate, Boston University, Honorary Founding President, In Memoriam

      Prix Galien Digital Health Award Committee 2021

      Bernard POUSSOT
      Director, Roche Holding, Former Chairman & CEO, Wyeth
      Committee Chair

      Roch DOLIVEUX
      Honorary CEO, UCB

      Mikael DOLSTEN, M.D., PH.D.
      Global R&D President, Pfizer

      Jean-Pierre GARNIER
      Former CEO, GSK

      Penny HEATON, M.D.
      CEO, Bill & Melinda Gates Medical Research Institute

      Franz HUMER, Ph.D.
      Former CEO, Roche

      François MAISONROUGE
      Senior Managing Director, Evercore Partners

      Sheri MCCOY
      Former CEO, Avon Products, Former Vice-Chairman, Johnson & Johnson

      Elias ZERHOUNI, M.D.
      Former Global Head of R&D, Sanofi

      About the Galien Foundation

      The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives.

      The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries and Africa. The Prix Galien was created in 1970 by Roland Mehl in honor of Galien, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

      For more information, visit www.galienfoundation.org.

      Follow the Foundation on social media:
      https://www.facebook.com/GalienFoundation/ 
      https://twitter.com/GalienFdn
      https://www.linkedin.com/company/the-galien-foundation/

      Media Contact:
      Kara Bradley
      Finn Partners
      [email protected]
      646-213-7243

      SOURCE The Galien Foundation

      Modal title

      Also from this source

      /C O R R E C T I O N - The Galien Foundation/

      /C O R R E C T I O N - The Galien Foundation/

      The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the nominees for the annual...

      The Galien Foundation Announces 2026 Prix Galien USA, International Prix Galien and Prix Galien Patient First Award Recipients

      The Galien Foundation Announces 2026 Prix Galien USA, International Prix Galien and Prix Galien Patient First Award Recipients

      The Galien Foundation, the premier global institution dedicated to honoring innovation in the life sciences, celebrated the 20th anniversary of the...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Biotechnology

      Biotechnology

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Medical Equipment

      Medical Equipment

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.